| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research |
Creighton University, Osteoporosis Research Center, Omaha, Nebraska (R.P.H., M.S.D., J.B.), GlaxoSmithKline, Parsippany, New Jersey (C.A.H., A.B.)
Creighton University, Osteoporosis Research Center, GlaxoSmithKline, Parsippany, New Jersey (C.A.H., A.B.)
Address reprint requests to: Robert P. Heaney, MD, Creighton University, Osteoporosis Research Center, 601 North 30th Street—Suite 4841, Omaha, NE 68131. E-mail: rheaney{at}creighton.edu
Background: Cost-effectiveness of calcium supplementation depends not only on the cost of the product but on the efficiency of its absorption. Published cost-benefit analyses assume equal bioavailability for all calcium sources. Some published studies have suggested that there are differences in both the bioavailability and cost of the major calcium supplements.
Design: Randomized four period, three-way cross-over comparing single doses of off-the-shelf commercial calcium supplements containing either calcium carbonate or calcium citrate compared with a no-load blank and with encapsulated calcium carbonate devoid of other ingredients; subjects rendered fully vitamin D-replete with 10 µg/day 25(OH)D by mouth, starting one week prior to the first test.
Subjects: 24 postmenopausal women
Methods: Pharmacokinetic analysis of the increment in serum total and ionized calcium and the decrement in serum iPTH induced by an oral calcium load, based upon multiple blood samples over a 24-hour period; measurement of the rise in urine calcium excretion. Data analyzed by repeated measures ANOVA. Cost calculations based on average retail prices of marketed products used in this study from April through October, 2000.
Results: All three calcium sources (marketed calcium carbonate, encapsulated calcium carbonate and marketed calcium citrate) produced identical 24-hour time courses for the increment in total serum calcium. Thus, these were equally absorbed and had equivalent bioavailability. Urine calcium rose slightly more with the citrate than with the carbonate preparations, but the difference was not significant. Serum iPTH showed the expected depression accompanying the rise in serum calcium, and there were no significant differences between products.
Conclusion: Given the equivalent bioavailability of the two marketed products, the cost benefit analysis favors the less expensive carbonate product.
Key words: calcium absorption, calcium carbonate, calcium citrate, bioavailability, cost-effectiveness
This article has been cited by other articles:
|
|
 |
|
  J. M Lappe, D. Travers-Gustafson, K M. Davies, R. R Recker, and R. P Heaney Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1586 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Straub Calcium Supplementation in Clinical Practice: A Review of Forms, Doses, and Indications Nutr Clin Pract, June 1, 2007; 22(3): 286 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Napoli, J. Thompson, R. Civitelli, and R. C Armamento-Villareal Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1428 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Barger-Lux, K. M. Davies, and R. P. Heaney Calcium Supplementation Does Not Augment Bone Gain in Young Women Consuming Diets Moderately Low in Calcium J. Nutr., October 1, 2005; 135(10): 2362 - 2366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A Abrams, I. J Griffin, K. M Hawthorne, L. Liang, S. K Gunn, G. Darlington, and K. J Ellis A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents Am. J. Clinical Nutrition, August 1, 2005; 82(2): 471 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Hanzlik, S. C. Fowler, and D. H. Fisher Relative Bioavailability of Calcium from Calcium Formate, Calcium Citrate, and Calcium Carbonate J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1217 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Baron, M. Beach, K. Wallace, M. V. Grau, R. S. Sandler, J. S. Mandel, D. Heber, and E. R. Greenberg Risk of Prostate Cancer in a Randomized Clinical Trial of Calcium Supplementation Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 586 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P Heaney Sensitivity of parathyroid hormone response to calcium intake Am. J. Clinical Nutrition, September 1, 2003; 78(3): 493 - 493. [Full Text] [PDF]
|
|
|
|
|
|
R. J Wood and L. Martini Reply to RP Heaney Am. J. Clinical Nutrition, September 1, 2003; 78(3): 493 - 495. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Abrams and S. A. Atkinson Calcium, Magnesium, Phosphorus and Vitamin D Fortification of Complementary Foods J. Nutr., September 1, 2003; 133(9): 2994S - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Heaney, M. S. Dowell, C. A. Hale, and A. Bendich Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D J. Am. Coll. Nutr., April 1, 2003; 22(2): 142 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Calcium Supplements Differ Only Slightly Journal Watch Women's Health, September 6, 2001; 2001(906): 2 - 2. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
